These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

584 related articles for article (PubMed ID: 25654551)

  • 21. Regulation of autophagy by some natural products as a potential therapeutic strategy for cardiovascular disorders.
    Hashemzaei M; Entezari Heravi R; Rezaee R; Roohbakhsh A; Karimi G
    Eur J Pharmacol; 2017 May; 802():44-51. PubMed ID: 28238768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiotensin II-type 2 receptor: emerging target for cardiovascular protection.
    Schmieder RE
    Am J Hypertens; 2010 Mar; 23(3):220. PubMed ID: 20154649
    [No Abstract]   [Full Text] [Related]  

  • 23. Targeting Rho and Rho-kinase in the treatment of cardiovascular disease.
    Budzyn K; Marley PD; Sobey CG
    Trends Pharmacol Sci; 2006 Feb; 27(2):97-104. PubMed ID: 16376997
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NO/redox disequilibrium in the failing heart and cardiovascular system.
    Hare JM; Stamler JS
    J Clin Invest; 2005 Mar; 115(3):509-17. PubMed ID: 15765132
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms of estrogen action in the cardiovascular system.
    Mendelsohn ME
    J Steroid Biochem Mol Biol; 2000 Nov; 74(5):337-43. PubMed ID: 11162942
    [No Abstract]   [Full Text] [Related]  

  • 26. The role of autophagy in vascular biology.
    Nussenzweig SC; Verma S; Finkel T
    Circ Res; 2015 Jan; 116(3):480-8. PubMed ID: 25634971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vascular autophagy in health and disease.
    Hughes WE; Beyer AM; Gutterman DD
    Basic Res Cardiol; 2020 Jun; 115(4):41. PubMed ID: 32506214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patterns of drug-induced cardiovascular pathology in the beagle dog: relevance for humans.
    Greaves P
    Exp Toxicol Pathol; 1998 Sep; 50(4-6):283-93. PubMed ID: 9784000
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design of multifunctional compounds for cardiovascular disease: from natural scaffolds to "classical" multitarget approach.
    Bisi A; Gobbi S; Belluti F; Rampa A
    Curr Med Chem; 2013; 20(13):1759-82. PubMed ID: 23410171
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Basic science review: Statin therapy--Part I: The pleiotropic effects of statins in cardiovascular disease.
    Sadowitz B; Maier KG; Gahtan V
    Vasc Endovascular Surg; 2010 May; 44(4):241-51. PubMed ID: 20403949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The potential use of the pregnane X receptor in cardiovascular therapy.
    Swales KE; Bishop-Bailey D
    Expert Rev Cardiovasc Ther; 2012 Sep; 10(9):1079-82. PubMed ID: 23098141
    [No Abstract]   [Full Text] [Related]  

  • 32. Cardiovascular autophagy: concepts, controversies, and perspectives.
    Lavandero S; Troncoso R; Rothermel BA; Martinet W; Sadoshima J; Hill JA
    Autophagy; 2013 Oct; 9(10):1455-66. PubMed ID: 23959233
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exercise-mediated regulation of autophagy in the cardiovascular system.
    Wang L; Wang J; Cretoiu D; Li G; Xiao J
    J Sport Health Sci; 2020 May; 9(3):203-210. PubMed ID: 32444145
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic targeting of autophagy: potential and concerns in treating cardiovascular disease.
    Orogo AM; Gustafsson ÅB
    Circ Res; 2015 Jan; 116(3):489-503. PubMed ID: 25634972
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Arterial wall: a new pharmacological and therapeutic target?].
    Laurent S; Vanhoutte P; Cavero I; Chabrier PE; Dupuis B; Elghozi JL; Hamon G; Janiak P; Juillet Y; Kher A
    Therapie; 1995; 50(4):387-98. PubMed ID: 7482394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of insulin resistance on endothelial function, progenitor cells and repair.
    Cubbon RM; Rajwani A; Wheatcroft SB
    Diab Vasc Dis Res; 2007 Jun; 4(2):103-11. PubMed ID: 17654443
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The application of phenotypic high-throughput screening techniques to cardiovascular research.
    Etzion Y; Muslin AJ
    Trends Cardiovasc Med; 2009 Aug; 19(6):207-12. PubMed ID: 20211437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of magnesium in cardiovascular diseases.
    Kolte D; Vijayaraghavan K; Khera S; Sica DA; Frishman WH
    Cardiol Rev; 2014; 22(4):182-92. PubMed ID: 24896250
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutical perspectives for apoptosis modulation in cardiovascular disease.
    Ginghină C; Crăciunescu I; Iorga V
    Rom J Intern Med; 2006; 44(3):213-22. PubMed ID: 18386601
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuropeptide Y: multiple receptors and multiple roles in cardiovascular diseases.
    Pons J; Lee EW; Li L; Kitlinska J
    Curr Opin Investig Drugs; 2004 Sep; 5(9):957-62. PubMed ID: 15503651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.